Adela Hasa-Moreno

959 total citations
7 papers, 407 citations indexed

About

Adela Hasa-Moreno is a scholar working on Molecular Biology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Adela Hasa-Moreno has authored 7 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Adela Hasa-Moreno's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Glycosylation and Glycoproteins Research (1 paper). Adela Hasa-Moreno is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Glycosylation and Glycoproteins Research (1 paper). Adela Hasa-Moreno collaborates with scholars based in United States. Adela Hasa-Moreno's co-authors include Davide Foletti, Arvind Rajpal, Pavel Strop, Meritxell Galindo Casas, Jaume Pons, David L. Shelton, Thomas-Toan Tran, Christopher J. O’Donnell, Kathy Delaria and Ludivine Moine and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Molecular Biology.

In The Last Decade

Adela Hasa-Moreno

7 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adela Hasa-Moreno United States 7 213 180 135 76 61 7 407
Minako Oshima United States 15 135 0.6× 146 0.8× 48 0.4× 148 1.9× 88 1.4× 53 793
Lucía Vanrell Spain 13 280 1.3× 85 0.5× 72 0.5× 43 0.6× 77 1.3× 20 453
Daniel Laune France 10 184 0.9× 112 0.6× 95 0.7× 7 0.1× 70 1.1× 14 382
Anne B. Tolstrup Denmark 13 435 2.0× 153 0.8× 65 0.5× 21 0.3× 222 3.6× 19 631
Veronique De Brabandere Belgium 6 438 2.1× 90 0.5× 29 0.2× 78 1.0× 74 1.2× 8 633
Jeremy Kasanov United States 6 287 1.3× 74 0.4× 53 0.4× 33 0.4× 26 0.4× 6 372
Michèle Lieb France 8 232 1.1× 25 0.1× 55 0.4× 58 0.8× 151 2.5× 14 437
William Lin United States 9 158 0.7× 49 0.3× 66 0.5× 16 0.2× 71 1.2× 12 366
Pauline Bonvin Switzerland 9 160 0.8× 75 0.4× 127 0.9× 12 0.2× 174 2.9× 11 341

Countries citing papers authored by Adela Hasa-Moreno

Since Specialization
Citations

This map shows the geographic impact of Adela Hasa-Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adela Hasa-Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adela Hasa-Moreno more than expected).

Fields of papers citing papers by Adela Hasa-Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adela Hasa-Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adela Hasa-Moreno. The network helps show where Adela Hasa-Moreno may publish in the future.

Co-authorship network of co-authors of Adela Hasa-Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Adela Hasa-Moreno. A scholar is included among the top collaborators of Adela Hasa-Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adela Hasa-Moreno. Adela Hasa-Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Dorywalska, Magdalena, Russell G. Dushin, Ludivine Moine, et al.. (2016). Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design. Molecular Cancer Therapeutics. 15(5). 958–970. 162 indexed citations
2.
Shcherbatko, Anatoly, Davide Foletti, Kris Poulsen, et al.. (2016). Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies. Journal of Biological Chemistry. 291(23). 12254–12270. 29 indexed citations
3.
Yeung, Yik A., Davide Foletti, Xiaodi Deng, et al.. (2016). Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire. Nature Communications. 7(1). 13376–13376. 30 indexed citations
4.
Shcherbatko, Anatoly, Andrea Rossi, Davide Foletti, et al.. (2016). Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain. Journal of Biological Chemistry. 291(27). 13974–13986. 42 indexed citations
5.
Blarcom, Thomas Van, Andrea Rossi, Davide Foletti, et al.. (2014). Precise and Efficient Antibody Epitope Determination through Library Design, Yeast Display and Next-Generation Sequencing. Journal of Molecular Biology. 427(6). 1513–1534. 50 indexed citations
6.
Caballero, Armando R., Davide Foletti, Aihua Tang, et al.. (2014). Effectiveness of Alpha-toxin Fab Monoclonal Antibody Therapy in Limiting the Pathology ofStaphylococcus aureusKeratitis. Ocular Immunology and Inflammation. 23(4). 297–303. 13 indexed citations
7.
Foletti, Davide, Pavel Strop, Lee Shaughnessy, et al.. (2013). Mechanism of Action and In Vivo Efficacy of a Human-Derived Antibody against Staphylococcus aureus α-Hemolysin. Journal of Molecular Biology. 425(10). 1641–1654. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026